These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6274546

  • 1. Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease.
    Dibble JB, Sheridan P, Hampshire R, Hardy GJ, Losowsky MS.
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):373-83. PubMed ID: 6274546
    [Abstract] [Full Text] [Related]

  • 2. Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease.
    Dibble JB, Sheridan P, Hampshire R, Hardy GJ, Losowsky MS.
    Q J Med; 1982 Oct; 51(201):89-103. PubMed ID: 6981120
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981.
    Stanbury SW.
    J R Coll Physicians Lond; 1981 Oct; 15(4):205-9, 212-7. PubMed ID: 6976436
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D metabolism and osteomalacia in cystic fibrosis.
    Friedman HZ, Langman CB, Favus MJ.
    Gastroenterology; 1985 Mar; 88(3):808-13. PubMed ID: 3871414
    [Abstract] [Full Text] [Related]

  • 5. Reversible resistance to the renal action of parathyroid hormone in human vitamin D deficiency.
    Lewin IG, Papapoulos SE, Hendy GN, Tomlinson S, O'Riordan JL.
    Clin Sci (Lond); 1982 Apr; 62(4):381-7. PubMed ID: 6279352
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D metabolites and bone mineralization in man.
    Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A.
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [Abstract] [Full Text] [Related]

  • 7. Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis.
    Reid IR, Teitelbaum SL, Dusso A, Whyte MP.
    Am J Med; 1987 Aug; 83(2):350-4. PubMed ID: 3303928
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
    Jeon HJ, Kwon SH, Kim SW, Shin CS, Park KS, Kim SY, Cho BY, Lee HK.
    Horm Res; 2003 Aug; 60(3):127-33. PubMed ID: 12931040
    [Abstract] [Full Text] [Related]

  • 9. Persistence of parathyroid hypersecretion after vitamin D treatment in Asian vegetarians.
    Dandona P, Mohiuddin J, Weerakoon JW, Freedman DB, Fonseca V, Healey T.
    J Clin Endocrinol Metab; 1984 Sep; 59(3):535-7. PubMed ID: 6611345
    [Abstract] [Full Text] [Related]

  • 10. Osteomalacia after parathyroidectomy in patients with uremia.
    Felsenfeld AJ, Harrelson JM, Gutman RA, Wells SA, Drezner MK.
    Ann Intern Med; 1982 Jan; 96(1):34-9. PubMed ID: 7053699
    [Abstract] [Full Text] [Related]

  • 11. Bone disease after jejuno-ileal bypass for obesity.
    Compston JE, Horton LW, Laker MF, Ayers AB, Woodhead JS, Bull HJ, Gazet JC, Pilkington TR.
    Lancet; 1978 Jul 01; 2(8079):1-4. PubMed ID: 78209
    [Abstract] [Full Text] [Related]

  • 12. Treatment of vitamin D deficient osteomalacia may unmask autonomous hyperparathyroidism.
    Taylor AV, Wise PH.
    Postgrad Med J; 1997 Dec 01; 73(866):813-5. PubMed ID: 9497953
    [Abstract] [Full Text] [Related]

  • 13. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone.
    Fujita T, Nomura M, Okajima S, Furuya H.
    J Clin Endocrinol Metab; 1980 May 01; 50(5):927-31. PubMed ID: 6246136
    [Abstract] [Full Text] [Related]

  • 14. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
    Malluche HH, Goldstein DA, Massry SG.
    J Clin Invest; 1979 Mar 01; 63(3):494-500. PubMed ID: 429568
    [Abstract] [Full Text] [Related]

  • 15. Posterior urethral valves: Metabolic consequences in a cohort of patients.
    Sarhan O, Nakshabandi Z, Alghanbar M, Alotay A, Sherif I, Whitehead C, El-Husseini A.
    J Pediatr Urol; 2015 Aug 01; 11(4):216.e1-6. PubMed ID: 26096436
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov 01; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol.
    Hernandez JD, Wesseling K, Boechat MI, Gales B, Salusky IB.
    Nat Clin Pract Nephrol; 2007 Apr 01; 3(4):227-32. PubMed ID: 17389892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.